Salarius Pharmaceuticals, Inc.
SLRX
$0.698
-$0.0348-4.75%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.43M | 3.28M | 3.27M | 4.37M | 5.90M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 331.50K | 538.60K | 241.10K | 457.10K | 619.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 221.60K | -- | -- | -- | -- |
| Total Current Assets | 2.99M | 3.82M | 3.51M | 4.83M | 6.52M |
|
|
|||||
| Total Current Assets | 2.99M | 3.82M | 3.51M | 4.83M | 6.52M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 35.40K | 36.50K | 39.90K | 53.40K | 66.90K |
| Total Assets | 3.02M | 3.86M | 3.55M | 4.88M | 6.59M |
|
|
|||||
| Total Accounts Payable | 937.00K | 165.80K | 643.10K | 714.00K | 602.90K |
| Total Accrued Expenses | 352.40K | 439.90K | 535.40K | 403.30K | 406.70K |
| Short-term Debt | 221.90K | 328.80K | -- | 116.90K | 289.60K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.51M | 934.60K | 1.18M | 1.23M | 1.30M |
|
|
|||||
| Total Current Liabilities | 1.51M | 934.60K | 1.18M | 1.23M | 1.30M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 221.90K | 328.80K | -- | 116.90K | 289.60K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.51M | 934.60K | 1.18M | 1.23M | 1.30M |
|
|
|||||
| Common Stock & APIC | 83.44M | 83.38M | 81.86M | 81.71M | 81.64M |
| Retained Earnings | -81.92M | -80.46M | -79.49M | -78.06M | -76.35M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 1.51M | 2.92M | 2.38M | 3.65M | 5.29M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.51M | 2.92M | 2.38M | 3.65M | 5.29M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.51M | 2.92M | 2.38M | 3.65M | 5.29M |
|
|
|||||